Invictus MD Strategies (Invictus MD Strategies) Equity-to-Asset : 0.75 (As of Oct. 2019)

View and export this data going back to 2015. Start your Free Trial

What is Invictus MD Strategies Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Invictus MD Strategies's Total Stockholders Equity for the quarter that ended in Oct. 2019 was $71.08 Mil. Invictus MD Strategies's Total Assets for the quarter that ended in Oct. 2019 was $94.69 Mil. Therefore, Invictus MD Strategies's Equity to Asset Ratio for the quarter that ended in Oct. 2019 was 0.75.

The historical rank and industry rank for Invictus MD Strategies's Equity-to-Asset or its related term are showing as below:

IVITF's Equity-to-Asset is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.59
* Ranked among companies with meaningful Equity-to-Asset only.

Invictus MD Strategies Equity-to-Asset Historical Data

The historical data trend for Invictus MD Strategies's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invictus MD Strategies Equity-to-Asset Chart

Invictus MD Strategies Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Equity-to-Asset

0.69

0.43

0.80

0.88

0.75

Invictus MD Strategies Quarterly Data
	Jan15	Apr15	Jul15	Oct15	Jan16	Apr16	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19
Equity-to-Asset	Get a 7-Day Free Trial															0.82	0.75	0.74	0.77	0.75

Competitive Comparison of Invictus MD Strategies's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Invictus MD Strategies's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Invictus MD Strategies's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Invictus MD Strategies's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Invictus MD Strategies's Equity-to-Asset falls into.

Invictus MD Strategies Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Invictus MD Strategies's Equity to Asset Ratio for the fiscal year that ended in Jan. 2019 is calculated as

Equity to Asset (A: Jan. 2019 )	=	Total Stockholders Equity	/	Total Assets
	=	86.848	/	115.72
	=	0.75

Invictus MD Strategies's Equity to Asset Ratio for the quarter that ended in Oct. 2019 is calculated as

Equity to Asset (Q: Oct. 2019 )	=	Total Stockholders Equity	/	Total Assets
	=	71.078	/	94.687
	=	0.75

Invictus MD Strategies (OTCPK:IVITF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Invictus MD Strategies Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Invictus MD Strategies's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Invictus MD Strategies (Invictus MD Strategies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Invictus MD Strategies Corp (OTCPK:IVITF) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

595 Burrard Street, 16th floor, Vancouver, BC, CAN, V7X 1J1

Website

http://www.invictus-md.com

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.